E160 | From Bio-Tech to Tech-Bio: AI Meets Drug Discovery

Welcome to an eye-opening conversation at the intersection of artificial intelligence and biotechnology. In this episode, we explore how AI is redefining protein design, accelerating drug discovery, and personalizing medicine at scale.Joining us is Brian Keane, Chairman of the Board at Diagen AI — a trailblazing Canadian company using AI-powered molecular modeling to revolutionize therapeutic development. With a background in capital markets and a passion for next-gen healthtech, Brian shares how Diagen AI is not only optimizing drug development timelines, but also rescuing failed trials, creating novel diagnostics, and designing next-generation peptides and proteins.🔍 In This Episode, You’ll Discover:🧬 How AI is designing proteins beyond human comprehension⚗️ Why 90–95% of traditional drugs fail—and how AI can change that💊 The role of AI in de-risking drug discovery and shortening time-to-market🩺 How Diagen AI is collaborating with wet labs, biotech firms & global regulators🔄 What “drug reclamation” and “molecule reformulation” really mean🧠 Why human capital, not just data, remains a major differentiator in AI biotech📊 The emerging global ecosystems backing AI innovation (Canada, UAE, Europe)💡 How AI accelerates precision and personalized medicine for rare diseases, cancer, and diabetes🚀 The future of protein engineering: from discovery to deliveryAbout the Podcast: AI for Business Growth  is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future.This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights.AI For Business Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget. As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses. This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more. Dr. Andree Bates LinkedIn | Facebook | Twitter

There are no comments yet.

Please log in to write the first comment.